Next |
home / stock / vbiv / vbiv message board
Subject | By | Source | When |
---|---|---|---|
$VBIV no 1 in the Gaucho session | Monksdream | investorshub | 07/05/2023 8:23:32 PM |
Zoom Zoom WOOHOOOOOO WOOHOOOOOO $VBIV | weedtrader420 | investorshub | 07/05/2023 8:12:19 PM |
$VBIV: BBOOoooommmmmmmmm.............. moved now to $3.50 | makinezmoney | investorshub | 07/05/2023 8:02:51 PM |
$VBIV where is the squeeze? | cheynew | investorshub | 07/04/2023 4:43:59 PM |
$VBIV The gaining | cheynew | investorshub | 07/04/2023 11:59:28 AM |
What happened | phillymillions | investorshub | 07/02/2023 10:49:49 PM |
$VBIV Lets go go go go... Up up and away we go. | TIZZUNI | investorshub | 07/02/2023 8:09:10 PM |
The gaining up | cheynew | investorshub | 07/02/2023 7:03:23 PM |
$VBIV Price now | cheynew | investorshub | 07/02/2023 5:24:05 PM |
Big day on Monday | amitgupta | investorshub | 07/02/2023 12:06:59 AM |
MomentumIts now | cheynew | investorshub | 07/01/2023 2:45:39 AM |
Wild | Awl416 | investorshub | 06/30/2023 6:35:20 PM |
Yup | Awl416 | investorshub | 06/30/2023 6:17:29 PM |
Have a look at this | cheynew | investorshub | 06/27/2023 7:12:35 AM |
$VBIV The now | Atlanta1 | investorshub | 06/24/2023 4:37:34 AM |
short data if anyone is interested | MADDSTACKER | investorshub | 06/24/2023 1:44:57 AM |
got some short data | cheynew | investorshub | 06/23/2023 2:22:27 AM |
$VBIV MomentumIts trading | cheynew | investorshub | 06/22/2023 10:41:35 PM |
best news of the day | MADDSTACKER | investorshub | 06/22/2023 5:57:28 PM |
Price gaining | MERCURIAL | investorshub | 06/22/2023 4:18:34 PM |
News, Short Squeeze, Breakout and More Instantly...
PreHevbrio ® (Hepatitis B Vaccine [Recombinant]) global net revenue increased 105% year-over-year in the first quarter of 2024 compared to the first quarter of 2023 Initial encouraging tumor response data from randomized Phase 2b study of VBI-1901 in recurrent glioblastoma (GBM) anno...
PreHevbrio ® (Hepatitis B Vaccine [Recombinant]) global net revenue increased 234% year-over-year from 2022 to 2023 Preliminary 2024 PreHevbrio U.S. sales demonstrate continued growth, with approximately 65% of 2023 full-year volume sold in Q1 2024 alone Early data from randomize...